Philippe Laffont’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-822,133
Closed -$257M 71
2015
Q4
$257M Sell
822,133
-325,652
-28% -$97M 2.54% 15
2015
Q3
$312M Buy
1,147,785
+560,621
+95% +$172M 3.5% 13
2015
Q2
$178M Sell
587,164
-734,286
-56% -$219M 1.78% 19
2015
Q1
$393M Buy
1,321,450
+357,295
+37% +$102M 3.74% 9
2014
Q4
$248M Buy
+964,155
New +$241M 2.35% 17

Other funds holding AGN

Philippe Laffont's AGN Position: Q1 2016 in Review

Philippe Laffont sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 822,133 shares — an estimated $257M sold.

Philippe Laffont first reported a position in AGN in Q4 2014 and held it in 5 quarters. The position peaked at $393M in Q1 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Philippe Laffont reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Philippe Laffont sold 822,133 Allergan plc shares in Q1 2016, an estimated $257M.
  • Philippe Laffont first reported a position in Allergan plc in Q4 2014 and held it in 5 quarters.
  • Philippe Laffont's Allergan plc position peaked at $393M in Q1 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Coatue Management's 13F filing for Q1 2016, filed 16 May 2016.